CD19 and systemic lupus erythematosus: Active SLE patients with renal disorders showed higher OAS2 and OASL expression in PBMCs, OAS3 and OASL expression in CD19+ B cells, and OAS3 expression in CD4+ T cells than patients without the symptoms (P<0.05, Tables 4, 5, and 6).